The Controversy over Support Continues and the Hyperbole Increases
Bibliographic Data
| ID | 20336751 |
|---|---|
| Authors | Alan R Fleischman (corresponding author) |
| Year | 2015 |
| Volume | 45 |
| Issue | 1 |
| Pages | 42-44 |
| Publication date | 2015-01-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The Hastings Center Report (JOURNAL) |
| Journal identifiers | ISSN: 0093-0334 • E-ISSN: 1552-146X |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1002/hast.416 |
| PMID | 25600386 |
| OpenAlex | W2034463565 |
| Language | EN |
| References cited | 3 |
Two articles in this issue of the Hastings Center Report address the continuing controversy over the Surfactant, Positive Pressure, and Oxygenation Randomized Trial (SUPPORT). This controversy is part of a larger discussion about the appropriate regulatory framework for protecting human research participants in comparative effectiveness research (CER), a group of studies that aims to compare two “usual” or “standard” treatments in order to provide evidence of which treatment is most effective
Economics · Hyperbole · Metaphor · Order (exchange) · Political science · Randomized controlled trial · Cardiac Arrest and Resuscitation · Medicine · Neonatal Respiratory Health Research · Philosophy · Psychology · Respiratory Support and Mechanisms · Surgery
| Citation velocity | historical |
|---|---|
| Highly cited | No |